top of page
Stay up-to-date.
340Basics 340B Industry Report Volume 2 covers the following topics:
-
Manufacturer Reporting – 340B ESP
-
Eli Lilly’s Refusal to Pay Cialis at 340B a Clear Violation of the 340B Statute
-
AstraZeneca
-
Kalderos to Help Drug Companies Replace 340B Discounts with Rebates
-
Court Upholds Medicare Part B Reimbursement Cuts for 340B Drugs
-
Reps. Matsui and Stewart Introduce Legislation to Protect 340B Hospitals During COVID-19 Pandemic
Fill in the Form Below to
Download 340Basics' 340B Industry Updates Report Now
bottom of page